Rabbit Polyclonal Anti-SARS-CoV-2/SARS-CoV Spike Protein Antibody
| Applications | E, WB |
| Reactivities | SARS-CoV, SARS-CoV-2 |
| Conjugation | Unconjugated |
| Immunogen | SARS-CoV-2 Spike protein antibody was raised against a peptide corresponding to 17 amino acids within aa 410-460 near the center of SARS-CoV Spike glycoprotein. Predicted reactivity based on immunogen sequence: SARS-CoV-2 Spike protein: (identity 65%, homology 88%). Has been shown to react with SARS-CoV-2 protein (see QC images). |
Rabbit Polyclonal Anti-SARS-CoV-2 Spike Protein Antibody
| Applications | ELISA, WB |
| Reactivities | SARS-CoV, SARS-CoV-2 |
| Conjugation | Unconjugated |
| Immunogen | The antibody was raised against a peptide corresponding to 20 amino acids within the last 50 amino acids of SARS-CoV-2 Spike glycoprotein. Predicted reactivity based on immunogen sequence: SARS-CoV Spike proteins: 100% |
Rabbit Polyclonal Anti- SARS-CoV-2/SARS-CoV Spike Protein Antibody
| Applications | ELISA, WB |
| Reactivities | SARS-CoV, SARS-CoV-2 |
| Conjugation | Unconjugated |
| Immunogen | The antibody was raised against a peptide corresponding to 16 amino acids between aa 410-460 near the center of SARS-CoV Spike glycoprotein. |
SARS-CoV Spike Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of SARS-CoV Spike. |
| Modifications | Unmodified |
SARS-CoV Spike RBD Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of SARS-CoV Spike RBD. |
| Modifications | Unmodified |
SARS-CoV Spike S1 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | SARS-CoV |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of SARS-CoV Spike S1. |
| Modifications | Unmodified |
Germany
Japan
United Kingdom
China
